ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PIII vs DCGO // REVENUE GROWTH (YOY)

P3 Health Partners Inc. (Class A) (NASDAQ) VS. DocGo Inc. (NASDAQ) • 15-METRIC TALLY: PIII 4 — DCGO 2
▲ REVENUE GROWTH (YOY) LEADER: PIII
revenue-growth
-47.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PIII VS. DCGO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PIII DCGO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -18.50% -55.30% +36.80 PIII /operating-margins <GO>
Net Profit Margin -10.10% -60.00% +49.90 PIII /net-margins <GO>
Revenue Growth (YoY) ACTIVE -2.80% -47.70% +44.90 PIII /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 5/9 -4.00 DCGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.9 39.1 -3.20 DCGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $30.5M $27.0M $3.5M PIII /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PIII REV DCGO REV PIII GROSS % DCGO GROSS % PIII FCF DCGO FCF
FY 2025 $1.46B $322.2M — — -$91.2M $29.9M
FY 2024 $1.50B $616.6M — — -$110.1M $66.5M
FY 2023 $1.27B $624.3M — — -$76.0M -$64.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PIII // BETA —
DCGO // BETA —